Testing a new drug for the flu

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated.

WINSTON-SALEM, N.C.--- Doctors in Winston-Salem are using patients from the Piedmont to help in nationwide study of a new drug that could slow down and shorten the symptoms of the flu. 

As researchers across the country say the flu virus is starting to become resistant to Tamiflu, the current treatment for the illness, a doctor at Ardmore Family Practice is working with Winston-Salem based Clinical Trials of America to test a new drug they say the virus is not yet resistant to.

Principal Investigator Dr. Rob Rosen says, "the name of the game in treating the flu is to slow viral replication.  The idea is the virus gets in your body and multiplies quickly and if the virus can be stopped in its tracks before being multiplied over and over and over again the course of flu infection seems to be less severe and short in duration."

Dr. Rosen says drug companies are looking for newer, more common treatments because in the next few years Tamiflu likely won't be effective.

"I think there is concern in general as the flu virus starts to become resistant to current treatments when we no longer have treatments that are effective then patients are more at risk of having prolonged flu symptoms," says Rosen.

Patients in the study must be within the first two days of illness. Some are given a placebo, some the real drug. They must visit the doctor everyday and take notes about the symptoms.

While researchers say the drug is still 3 to 4 years from being approved and on the market they have high hopes this study will prove it to be effective.

If you would like more information about the study to take part check out http://ctamerica.net/


Notice: you are using an outdated browser. Microsoft does not recommend using IE as your default browser. Some features on this website, like video and images, might not work properly. For the best experience, please upgrade your browser.